You just read:

GlycoVaxyn AG Signs Exclusive License Agreement and Enters Research and Development Collaboration with Janssen Pharmaceuticals, Inc., to Develop Multi-Valent Bacterial Vaccine

News provided by

GlycoVaxyn AG

Jan 04, 2013, 11:10 EST